Stay updated on Anti-MAP Therapy in Crohn's: Clinical Trial
Sign up to get notified when there's something new on the Anti-MAP Therapy in Crohn's: Clinical Trial page.

Latest updates to the Anti-MAP Therapy in Crohn's: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe footer’s ClinicalTrials.gov revision changed from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange Detected403 Forbidden page is now shown, replacing the study record content. Related sections such as sponsor, investigators, and location information have been removed from the page.SummaryDifference18%

- Check33 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0 on the page, reflecting a new version of the study record. This update is metadata and does not change the study content, eligibility criteria, outcomes, or locations.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision: v3.6.6 updated on the page, signaling a new version of the document or assets. This is a backend/version control update rather than a substantive change to the study content.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page revision label was updated to v3.6.5, indicating a backend/template update rather than a change to the study details or results.SummaryDifference0.0%

- Check83 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4 on the study record pages, indicating a new build of the ClinicalTrials.gov interface. This change typically reflects bug fixes or minor UI improvements without altering the study information.SummaryDifference0.0%

Stay in the know with updates to Anti-MAP Therapy in Crohn's: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-MAP Therapy in Crohn's: Clinical Trial page.